Literature DB >> 16263011

Should HIV patients be considered a high risk group for the development of prostate cancer?

Nadine Quatan1, Sabarinath Nair, Fran Harrowes, Phillip Hay.   

Abstract

INTRODUCTION: Only very few case reports exist regarding the incidence of prostate cancer in younger HIV-infected patients. PATIENTS AND METHODS: Two incidences of HIV-infected men diagnosed with prostate cancer, from a cohort of about 200 men treated at St George's Hospital aged 40 years or more are reported. DISCUSSION: On the basis of the evidence presented in both case reports and from the literature, clinicians should be aware that men with HIV infection should be considered a high-risk group for prostate cancer, and consider early PSA screening.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263011      PMCID: PMC1964137          DOI: 10.1308/003588405X60696

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  5 in total

Review 1.  Management of prostate cancer in HIV-positive patients.

Authors:  Matthew S Wosnitzer; Franklin C Lowe
Journal:  Nat Rev Urol       Date:  2010-04-27       Impact factor: 14.432

Review 2.  Urologic complications of HIV and AIDS.

Authors:  Chris F Heyns; Adam E Groeneveld; Nelson B Sigarroa
Journal:  Nat Clin Pract Urol       Date:  2009-01

3.  Clinical characteristics and outcomes of robot-assisted laparoscopic radical prostatectomy in HIV-positive patients: a nationwide population-based analysis.

Authors:  Hedong Han; Chen Ye; Zhongjun Tang; Yingyi Qin; Yiming Ruan; Yang Cao; Jia He
Journal:  Int Urol Nephrol       Date:  2019-11-02       Impact factor: 2.370

4.  Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer.

Authors:  Sudeh Izadmehr; Michael Leapman; Adele R Hobbs; Maria Katsigeorgis; Fatima Nabizada-Pace; Seyed Behzad Jazayeri; David B Samadi
Journal:  Int Urol Nephrol       Date:  2016-06-18       Impact factor: 2.370

Review 5.  Is There an Optimal Curative Option in HIV-Positive Men with Localized Prostate Cancer? A Systematic Review.

Authors:  John Baladakis; Marlon Perera; Damien Bolton; Nathan Lawrentschuk; Ahmed Adam
Journal:  Curr Urol       Date:  2019-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.